Mounjaro Pen (tirzepatide)

Mounjaro (Tirzepatide) is a prescription medication used to improve blood sugar control in adults with type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists and dual GIP receptor agonists. Mounjaro works by stimulating insulin production, reducing the amount of glucose produced by the liver, and slowing down the digestion of food, which helps control blood sugar levels.

In addition to its use in diabetes management, Mounjaro has also shown promise in promoting weight loss, making it a potential option for individuals with obesity or overweight conditions, though it’s not yet approved for this specific use. Mounjaro is typically administered as a once-weekly injection and is often used in combination with diet and exercise to achieve optimal results in managing type 2 diabetes. However, it is not suitable for treating type 1 diabetes or diabetic ketoacidosis.